Feng Heting, Gong Song, Liu Jiafeng, Aghayants Sis, Liu Yiling, Wu Min, Wu Yiping, Song Jingyu
Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, Hubei, China.
Division of Endocrinology, Tongji Hospital, Huazhong University of Science and Technology, Jiefang Road 1095, Wuhan, 430030, Hubei Province, People's Republic of China.
Biomark Res. 2025 Jun 20;13(1):88. doi: 10.1186/s40364-025-00801-2.
Wound healing is a complex, multi-stage process that restores skin integrity through coordinated cellular and molecular interactions. Among the emerging therapeutic strategies, adipose-derived stem cell exosomes (ADSC-Exos) attract significant attention due to their potent regenerative capabilities. ADSC-Exos contribute to wound repair by modulating inflammatory responses, promoting cellular proliferation and migration, stimulating angiogenesis, and facilitating collagen remodeling. These exosomes carry a diverse array of bioactive molecules including cytokines, non-coding RNAs (ncRNAs), and proteins, that are delivered to target cells, thereby orchestrating the intricate processes involved in tissue regeneration. Recent advancements in exosome engineering, such as genetic modification, pharmacological preconditioning, hypoxic treatment, and incorporation with biomaterials, markedly improve the therapeutic efficacy of ADSC-Exos. This review summarizes the underlying mechanisms and therapeutic potential of ADSC-Exos in wound healing, offering new perspectives for developing exosome-based regenerative therapies. Nevertheless, challenges persist regarding the large-scale production, standardized isolation, and clinical translation of ADSC-Exos. Future research should aim to enhance exosome yield and purity, elucidate the mechanisms governing exosome biogenesis, and validate their clinical efficacy through well-designed trials.
伤口愈合是一个复杂的多阶段过程,通过协调细胞和分子相互作用来恢复皮肤完整性。在新兴的治疗策略中,脂肪来源的干细胞外泌体(ADSC-Exos)因其强大的再生能力而备受关注。ADSC-Exos通过调节炎症反应、促进细胞增殖和迁移、刺激血管生成以及促进胶原蛋白重塑来促进伤口修复。这些外泌体携带多种生物活性分子,包括细胞因子、非编码RNA(ncRNAs)和蛋白质,它们被递送至靶细胞,从而协调组织再生中涉及的复杂过程。外泌体工程的最新进展,如基因修饰、药物预处理、低氧处理以及与生物材料结合,显著提高了ADSC-Exos的治疗效果。本综述总结了ADSC-Exos在伤口愈合中的潜在机制和治疗潜力,为开发基于外泌体的再生疗法提供了新的视角。然而,ADSC-Exos的大规模生产、标准化分离和临床转化仍然存在挑战。未来的研究应致力于提高外泌体的产量和纯度,阐明外泌体生物发生的机制,并通过精心设计的试验验证其临床疗效。